Data / Research funding / Colorado / National Jewish Health
National Jewish Health: 92 NIH awards ($175.1M), fiscal years 2021 to 2026
National Jewish Health in Denver, CO is funded under 92 NIH awards ($175.1M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- VLQKFEEJ3NE9
- State
- Colorado
Awards
92 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| COPD GENE - GENETIC EPIDEMIOLOGY OF COPD - TASK AREA A: YEAR 3 - AUGUST 10, 2025 - AUGUST 9, 2026 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $29,553,568 | August 10, 2025 | August 9, 2026 | NEWMAN, LEE S | reporter.nih.gov |
| ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,224,161 | April 9, 2020 | March 31, 2027 | LEUNG, DONALD YM | reporter.nih.gov |
| (1 of 2) Genetic Epidemiology of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 | $6,661,979 | September 27, 2007 | July 31, 2023 | CRAPO, JAMES D | reporter.nih.gov |
| Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,964,079 | January 1, 2022 | December 31, 2028 | MAJKA, SUSAN M | reporter.nih.gov |
| Lung Macrophage Programming in Acute Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,783,173 | February 15, 2018 | January 31, 2026 | JANSSEN, WILLIAM | reporter.nih.gov |
| Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,954,211 | April 15, 2012 | February 28, 2027 | GERBER, ANTHONY N | reporter.nih.gov |
| Parkin in mitochondrial dysfunction and airway inflammation of obese asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,892,074 | September 16, 2020 | August 31, 2025 | CHU, HONG W | reporter.nih.gov |
| SUNBEAM Birth Cohort Supplement | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,806,605 | September 6, 2024 | June 30, 2029 | SEIBOLD, MAX A | reporter.nih.gov |
| Proteolysis in the Pathogenesis of ARDS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,785,315 | December 22, 2021 | November 30, 2025 | DOWNEY, GREGORY PAUL | reporter.nih.gov |
| MDS-Associated Spliceosome Mutations Regulate Host Defense | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,696,549 | March 11, 2021 | February 28, 2027 | ALPER, SCOTT | reporter.nih.gov |
| Ceramide-Induced Destruction in Emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,661,589 | July 1, 2006 | April 30, 2025 | PETRACHE, IRINA | reporter.nih.gov |
| Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,590,938 | February 9, 2022 | November 30, 2026 | MAIER, LISA A | reporter.nih.gov |
| DNA induction of neutrophilic asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,455,981 | September 17, 2021 | August 31, 2026 | ALAM, RAFEUL | reporter.nih.gov |
| Asthma susceptibility due to environmental programming of innate immunity in utero | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,448,755 | January 1, 2015 | November 30, 2025 | GORSKA, MAGDALENA MARIA | reporter.nih.gov |
| ILC2 memory in asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,440,552 | September 21, 2020 | August 31, 2025 | ALAM, RAFEUL | reporter.nih.gov |
| Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,437,769 | March 1, 2020 | February 28, 2026 | LEUNG, DONALD YM | reporter.nih.gov |
| Predictive Models of Beryllium Sensitization and Chronic Beryllium Disease | NIH | National Institute of Environmental Health Sciences | 2023 | $2,413,505 | September 10, 2023 | August 31, 2026 | LI, LI | reporter.nih.gov |
| Molecular Characterization of Progressive Pulmonary Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,384,181 | September 1, 2023 | July 31, 2027 | MAIER, LISA A | reporter.nih.gov |
| Optimization of AEOL10150 treatment of sulfur mustard-induced lung toxidrome in a pig model | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,332,659 | September 1, 2018 | May 31, 2025 | DAY, BRIAN J | reporter.nih.gov |
| Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,318,122 | July 25, 2021 | April 30, 2027 | BRATCHER, PRESTON E | reporter.nih.gov |
| Roles for interstitial and airspace macrophages in resolution of pulmonary inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,237,353 | June 1, 2020 | May 31, 2025 | HENSON, PETER M | reporter.nih.gov |
| Role of immunoproteasome in airway viral infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,230,937 | May 1, 2020 | April 30, 2026 | CHU, HONG W | reporter.nih.gov |
| Mechanisms of right ventricle adaptation to pulmonary hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,213,677 | September 1, 2019 | June 30, 2028 | LAHM, TIM | reporter.nih.gov |
| The Origin and Role of Pulmonary ILC2 Subsets in Anti-Helminth Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,212,932 | September 21, 2020 | August 31, 2025 | REINHARDT, RICHARD LEE | reporter.nih.gov |
| Role of FABP5 in COPD Exacerbations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,179,399 | June 15, 2019 | June 30, 2028 | GALLY, FABIENNE | reporter.nih.gov |
| Loss of progenitor function accelerates lung aging | NIH | National Institute on Aging | 2023 to 2025 | $2,062,620 | June 15, 2023 | February 29, 2028 | MAJKA, SUSAN M | reporter.nih.gov |
| Transcriptional Control of T Cell Function | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,037,700 | March 22, 2021 | February 28, 2027 | SCOTT-BROWNE, JAMES | reporter.nih.gov |
| An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,004,943 | August 15, 2017 | June 30, 2025 | BENDER, BRUCE GEORGE | reporter.nih.gov |
| Maternal programming of the stem cell-basophil axis for asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,932,227 | July 20, 2020 | June 30, 2025 | GORSKA, MAGDALENA MARIA | reporter.nih.gov |
| Interaction of fibroblasts with cell corpses increases collagen synthesis during lung repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,848,746 | July 1, 2023 | June 30, 2028 | MCCUBBREY, ALEXANDRA LEIGH | reporter.nih.gov |
| GM-CSF, macrophages, and susceptibility to Mycobacterium abscessus pulmonary infection | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,839,635 | May 1, 2023 | April 30, 2028 | HISERT, KATHERINE B | reporter.nih.gov |
| Defining Molecular Phenotypes of Exacerbation Prone Asthmatics | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,782,623 | September 1, 2017 | August 31, 2024 | SEIBOLD, MAX A | reporter.nih.gov |
| Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,650,060 | August 1, 2020 | July 31, 2025 | FERNANDEZ, EVANS | reporter.nih.gov |
| ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,648,190 | April 10, 2020 | March 31, 2027 | LEUNG, DONALD YM | reporter.nih.gov |
| Reducing Fibroblast Persistence in Pulmonary Fibrosis as a Mechanism of Resolution | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,624,935 | August 1, 2019 | July 31, 2025 | REDENTE, ELIZABETH FRANCES | reporter.nih.gov |
| Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis | NIH | National Center for Advancing Translational Sciences | 2021 | $1,511,058 | April 10, 2018 | June 30, 2025 | DOWNEY, GREGORY PAUL | reporter.nih.gov |
| Use of blinded tapering for hypnotic discontinuation | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,382,226 | July 1, 2019 | April 30, 2025 | SMITH, ELIZABETH DEVON | reporter.nih.gov |
| Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,357,512 | April 1, 2024 | March 31, 2028 | REDENTE, ELIZABETH FRANCES | reporter.nih.gov |
| Histone Arginine Demethylation through Cleavage | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,287,059 | September 8, 2020 | August 31, 2025 | ZHANG, GONGYI | reporter.nih.gov |
| Novel integrative approaches for disease phenotyping, utilizing radiomics in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,262,108 | April 1, 2019 | March 31, 2025 | FINGERLIN, TASHA E. | reporter.nih.gov |
| Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,254,964 | September 18, 2018 | April 30, 2024 | BRATTON, DONNA L | reporter.nih.gov |
| Regulation of Gene Expression in the anaphylactic Pathway | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,209,904 | May 15, 2018 | April 30, 2024 | HUANG, HUA | reporter.nih.gov |
| Reparative functions of human airspace macrophage subsets | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,205,910 | July 15, 2024 | June 30, 2029 | MOULD, KARA J | reporter.nih.gov |
| Molecular Mechanisms of Immune Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,146,489 | August 1, 2009 | June 30, 2025 | PELANDA, ROBERTA | reporter.nih.gov |
| Temporal regulation of pulmonary inflammation by MyD88 alternative pre-mRNA splicing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,127,446 | June 1, 2019 | May 31, 2024 | ALPER, SCOTT | reporter.nih.gov |
| Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,073,762 | August 1, 2023 | June 30, 2028 | SMITH, ELIZABETH DEVON | reporter.nih.gov |
| Characteristics of T Cell Receptors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,014,362 | May 1, 1982 | November 30, 2023 | MARRACK, PHILIPPA C. | reporter.nih.gov |
| A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 | $992,527 | April 15, 2018 | February 28, 2023 | LEACH, SONIA | reporter.nih.gov |
| Biomarker of Lung Disease in African Americans | NIH | National Heart, Lung, and Blood Institute | 2021 | $934,082 | August 15, 2018 | May 31, 2023 | BOWLER, RUSSELL PAUL | reporter.nih.gov |
| Steroid resistance of airway ILC2s | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $911,771 | May 15, 2018 | April 30, 2024 | ALAM, RAFEUL | reporter.nih.gov |
| Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $820,000 | January 23, 2019 | November 30, 2023 | NICK, JERRY A | reporter.nih.gov |
| Selenocyanate as a novel treatment of cystic fibrosis lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $795,886 | January 1, 2019 | November 30, 2023 | DAY, BRIAN J | reporter.nih.gov |
| Integrative Metabolomics of Sarcoidosis Diagnosis and Progression | NIH | National Heart, Lung, and Blood Institute | 2025 | $760,374 | April 1, 2025 | January 31, 2030 | LIAO, SHU-YI | reporter.nih.gov |
| Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema | NIH | National Heart, Lung, and Blood Institute | 2023 | $760,358 | July 1, 2023 | September 14, 2023 | SERBAN, KARINA | reporter.nih.gov |
| Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $735,011 | September 23, 2017 | June 30, 2024 | WECHSLER, MICHAEL E | reporter.nih.gov |
| Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children | NIH | National Heart, Lung, and Blood Institute | 2021 | $729,775 | May 1, 2017 | April 30, 2024 | SEIBOLD, MAX A | reporter.nih.gov |
| National Jewish Health CoFAR Clinical Research Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $704,994 | March 2, 2017 | February 29, 2024 | LEUNG, DONALD YM | reporter.nih.gov |
| Role of the SFTA2/ADGRF5 signaling axis in alveolar homeostasis | NIH | National Heart, Lung, and Blood Institute | 2025 | $702,103 | September 1, 2025 | June 30, 2029 | BRIDGES, JAMES PATRICK | reporter.nih.gov |
| Epigenetic Regulation of Immune Pathways in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 | $697,552 | July 1, 2018 | June 30, 2023 | MAIER, LISA A | reporter.nih.gov |
| Interstitial macrophages in cigarette smoke-induced small airway remodeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $633,312 | January 1, 2022 | December 31, 2026 | HUME, PATRICK SCOTT | reporter.nih.gov |
| Role of Lung MSC in Emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 | $616,754 | March 21, 2019 | December 31, 2021 | MAJKA, SUSAN M | reporter.nih.gov |
| Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 | $614,709 | February 1, 2018 | December 31, 2022 | RICHES, DAVID W. | reporter.nih.gov |
| Mast Cell Lineage Commitment and Function | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $612,328 | December 2, 2024 | November 30, 2029 | HUANG, HUA | reporter.nih.gov |
| Lung MSC regulate angiogenesis and repair during fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 | $611,477 | February 15, 2018 | December 31, 2021 | MAJKA, SUSAN M | reporter.nih.gov |
| Transcriptional Responses to Wildfire Pollution in Airway Epithelial Cells Identify Genetic Risk Factors and Mechanisms of Asthma Exacerbations | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $522,504 | December 17, 2022 | November 30, 2027 | GUPTA, ARNAV | reporter.nih.gov |
| Macrophage Metabolism After Target Cell Ingestion Regulates Anti-Inflammatory Reprogramming | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $498,000 | August 15, 2020 | July 31, 2024 | MCCUBBREY, ALEXANDRA LEIGH | reporter.nih.gov |
| RNA editing controls pulmonary endothelial pathophenotypes in pulmonary hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $498,000 | September 1, 2024 | August 31, 2027 | WOODCOCK, CHEN-SHAN JULIA | reporter.nih.gov |
| Mannose binding lectin-dependent complement activation in emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $475,956 | December 17, 2018 | November 30, 2023 | SERBAN, KARINA | reporter.nih.gov |
| The Role of Airway Epithelial Complement in Chronic Beryllium Disease | NIH | National Institute of Environmental Health Sciences | 2024 | $470,500 | September 19, 2024 | August 31, 2026 | LI, LI | reporter.nih.gov |
| Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma | NIH | National Heart, Lung, and Blood Institute | 2021 | $465,888 | September 20, 2018 | August 31, 2023 | CHU, HONG W | reporter.nih.gov |
| Single Cell Genomics to Resolve Control of Immune Cell Function During Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $463,279 | June 26, 2023 | May 31, 2026 | SCOTT-BROWNE, JAMES | reporter.nih.gov |
| Repurposing thiosulfate for chlorine gas exposure | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $450,291 | August 18, 2021 | July 31, 2024 | DAY, BRIAN J | reporter.nih.gov |
| Environmental Factors Predicting Risk of Severe COVID Infection | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $447,800 | September 14, 2021 | August 31, 2024 | REGAN, ELIZABETH ANNE | reporter.nih.gov |
| Evaluating regimen efficacy using transcriptomic patterns of Mycobacterium tuberculosis injury and adaptation: high dimensional pharmacodynamics as a steppingstone to rational regimen design. | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $429,546 | August 8, 2025 | July 31, 2027 | MOORE, CAMILLE M. | reporter.nih.gov |
| Mechanism of Prostone Activation During CFTR Modulation | NIH | National Heart, Lung, and Blood Institute | 2022 | $426,793 | September 19, 2022 | August 31, 2024 | ZEITLIN, PAMELA L. | reporter.nih.gov |
| Discovery of Novel Mechanisms of Action of Ubiquitin-Like Proteins in Cellular Stress Pathways | NIH | National Institute of General Medical Sciences | 2024 | $414,049 | July 1, 2020 | April 30, 2026 | RADOSHEVICH, LILLIANA | reporter.nih.gov |
| Loss of progenitor function accelerates lung aging | NIH | National Institute on Aging | 2021 | $336,200 | September 1, 2021 | June 14, 2023 | MAJKA, SUSAN M | reporter.nih.gov |
| Metabolic Reprogramming of Recruited Alveolar Macrophages by Arginine In Acute Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $319,248 | April 9, 2018 | March 31, 2024 | MOULD, KARA J | reporter.nih.gov |
| Modulating macrophage-mediated Inflammation in cystic fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $315,578 | April 1, 2018 | June 30, 2023 | HISERT, KATHERINE B | reporter.nih.gov |
| Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $313,632 | July 15, 2024 | June 30, 2029 | COOLEY, JOSEPH CHARLES | reporter.nih.gov |
| Transcriptional Regulation of the Il13 Gene in Mast Cells | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $251,972 | January 4, 2024 | December 31, 2024 | HUANG, HUA | reporter.nih.gov |
| Common and distinct metabolic pathways of pulmonary sarcoidosis phenotypes and endotypes | NIH | National Heart, Lung, and Blood Institute | 2025 | $249,000 | July 1, 2025 | June 30, 2027 | LIAO, SHU-YI | reporter.nih.gov |
| Innate Immune Signal Transduction Specificity in Inflammatory Disease | NIH | National Institute of General Medical Sciences | 2025 | $237,651 | May 1, 2021 | January 31, 2027 | ABBOTT, DEREK W | reporter.nih.gov |
| Transcriptional control of T cell function during type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $230,752 | January 1, 2024 | December 31, 2028 | SHAW, LAURA | reporter.nih.gov |
| MicroRNA as Diagnostic and Prognostic Biomarkers in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2023 | $182,533 | May 5, 2023 | September 1, 2023 | LIN, NANCY WEIJIUN | reporter.nih.gov |
| The Anti-Cyclic Citrullinated Protein Antibody Repertoire and Lung Involvement in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $174,645 | September 4, 2020 | August 31, 2024 | SOLOMON, JOSHUA | reporter.nih.gov |
| Aspen Lung Conference: Bridging the Gap between Innate and Adaptive Immunity in the Lung | NIH | National Heart, Lung, and Blood Institute | 2022 | $33,000 | April 1, 2022 | March 31, 2023 | MAIER, LISA A | reporter.nih.gov |
| Prostones as novel receptor-mediated activators of CFTR in the airway | NIH | National Heart, Lung, and Blood Institute | 2021 | $32,997 | May 1, 2021 | October 31, 2021 | SHAUGHNESSY, CIARAN | reporter.nih.gov |
| Genomic Analysis of Epithelial Growth and Repair Mechanisms in Aspirin Exacerbated Respiratory Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $31,862 | September 16, 2018 | May 31, 2021 | MODENA, BRIAN DAVID | reporter.nih.gov |
| Aspen Lung Conference: Asthma: Pathogenesis, Phenotypes, Therapies and Gaps | NIH | National Heart, Lung, and Blood Institute | 2023 | $30,000 | May 1, 2023 | April 30, 2024 | GERBER, ANTHONY N | reporter.nih.gov |
| Aspen Lung Conference Pulmonary Fibrosis - focusing on the future | NIH | National Heart, Lung, and Blood Institute | 2024 | $30,000 | April 1, 2024 | March 31, 2025 | REDENTE, ELIZABETH FRANCES | reporter.nih.gov |
| Distinct responses of lung macrophages and airway epithelial cells to Hawai'i-derived volcanic ash and nontuberculous mycobacteria | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $1 | March 22, 2023 | April 1, 2023 | HONDA, JENNIFER R. | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 31 | $33,990,176 | 0 | $0 |
| 2024 | 40 | $35,042,128 | 0 | $0 |
| 2023 | 41 | $31,499,396 | 0 | $0 |
| 2022 | 48 | $29,699,122 | 0 | $0 |
| 2021 | 55 | $44,878,410 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 1 award here | |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.838 | December 3, 2026 | Not listed | Same assistance listing 93.838 as 50 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.838 | December 3, 2026 | Not listed | Same assistance listing 93.838 as 50 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.838 | December 4, 2026 | Not listed | Same assistance listing 93.838 as 50 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.838 | January 5, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.838 | January 5, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.838 | January 7, 2027 | $375,000 | Same assistance listing 93.838 as 50 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.838 | January 7, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-25-025 | NIH | 93.838 | February 3, 2027 | $1.5 million | Same assistance listing 93.838 as 50 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | PAR-25-026 | NIH | 93.838 | February 3, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) | PAR-27-125 | NIH | 93.838 | February 16, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) | RFA-DK-27-108 | NIH | 93.838 | March 10, 2027 | $500,000 | Same assistance listing 93.838 as 50 awards here |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) | PAR-25-032 | NIH | 93.838 | March 16, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.838 | April 5, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.838 | April 5, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) | RFA-OD-25-003 | NIH | 93.838 | April 9, 2027 | $200,000 | Same assistance listing 93.838 as 50 awards here |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) | RFA-HL-26-002 | NIH | 93.838 | April 28, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) | RFA-HL-26-003 | NIH | 93.838 | April 28, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | PA-24-175 | NIH | 93.838 | May 7, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.838 | May 7, 2027 | Not listed | Same assistance listing 93.838 as 50 awards here |
Topics of its NIH awards
- Lung
- Clinical Research
- Genetics
- Rare Diseases
- Prevention
- Infectious Diseases
- Asthma
- Women's Health
- Autoimmune Disease
- Human Genome
- Chronic Obstructive Pulmonary Disease
- Biotechnology
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.